FDA Working With Infant Formula Makers To Keep Products On U.S. Market

By Lia DeGroot / January 10, 2023 at 2:10 PM
FDA is working with 11 international infant formula manufacturers to keep their products available for sale in the United States under a policy of enforcement discretion while they work toward meeting the requirements to become lawfully marketed in the United States on a permanent basis, FDA announced Monday (Jan. 9) . The companies are on the U.S. market under FDA’s enforcement discretion policy, which allows certain infant formulas made overseas and intended for a foreign market, or products manufactured domestically...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.